Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy

American Journal of Ophthalmology

Volumn 153, Issue 5, 2012, Pages

  Sagong, Min ^a   Lim, Suho ^a   Chang, Woohyok ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; INDOCYANINE GREEN; VERTEPORFIN;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POLYP; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FOVEA; RETINA HEMORRHAGE; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT OUTCOME; UVEITIS; VISION; VISUAL ACUITY;

EID: 84859789154     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.09.031     Document Type: Article

References (41)

1. L.A. Yannuzzi, J. Sorenson, R.F. Spaide, B. Lipson Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1 1990 1 8 (Pubitemid 20201879)
2. L.A. Yannuzzi, D.W. Wong, B.S. Sforzolini Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 11 1999 1503 1510 (Pubitemid 29536478)
3. R.M. Ahuja, P.E. Stanga, J.R. Vingerling, A.C. Reck, A.C. Bird Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments Br J Ophthalmol 84 5 2000 479 484 (Pubitemid 30251708)
4. S.A. Pai, R. Shetty Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy Acta Ophthalmol 87 7 2009 806 807
5. A.P. Ciardella, I.M. Donsoff, S.J. Huang, D.L. Costa, L.A. Yannuzzi Polypoidal choroidal vasculopathy Surv Ophthalmol 49 1 2004 25 37 (Pubitemid 38056622)
6. K. Sho, K. Takahashi, H. Yamada Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 10 2003 1392 1396 (Pubitemid 37243739)
7. I. Maruko, T. Iida, M. Saito, D. Nagayama, K. Saito Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 1 2007 15 22
8. F. Wen, C. Chen, D. Wu, H. Li Polypoidal choroidal vasculopathy in elderly Chinese patients Graefes Arch Clin Exp Ophthalmol 242 8 2004 625 629 (Pubitemid 39242836)
9. S.H. Byeon, S.C. Lee, H.S. Oh, S.S. Kim, H.J. Koh, O.W. Kwon Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients Jpn J Ophthalmol 52 1 2008 57 62 (Pubitemid 351462228)
10. R.A. Costa, E.V. Navajas, M.E. Farah, D. Calucci, J.A. Cardillo, I.U. Scott Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm Prog Retin Eye Res 24 5 2005 560 586 (Pubitemid 40943662)
11. R.H. Rosa Jr, J.L. Davis, C.W. Eifrig Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 120 4 2002 502 508 (Pubitemid 34727825)
12. M. Yuzawa, R. Mori, A. Kawamura The origins of polypoidal choroidal vasculopathy Br J Ophthalmol 89 5 2005 602 607 (Pubitemid 40569719)
13. A. Otani, M. Sasahara, Y. Yodoi Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
14. E. Akaza, M. Yuzawa, Y. Matsumoto, S. Kashiwakura, K. Fujita, R. Mori Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 4 2007 270 277 (Pubitemid 47174610)
15. W.M. Chan, D.S. Lam, T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 8 2004 1576 1584 (Pubitemid 39030815)
16. F. Gomi, M. Ohji, K. Sayanagi One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 1 2008 141 146 (Pubitemid 350309415)
17. Y. Hirami, A. Tsujikawa, A. Otani Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy Retina 27 3 2007 335 341 (Pubitemid 46398898)
18. R.M. Silva, J. Figueira, M.L. Cachulo, L. Duarte, J.R. Faria de Abreu, J.G. Cunha-Vaz Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 10 2005 973 979 (Pubitemid 41631036)
19. C.M. Eandi, M.D. Ober, K.B. Freund, J.S. Slakter, L.A. Yannuzzi Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization Retina 27 7 2007 825 831 (Pubitemid 47479375)
20. U. Schmidt-Erfurth, H. Laqua, U. Schltzer-Schrehard, A. Viestenz, G.O. Naumann Histopathological changes following photodynamic therapy in human eyes Arch Ophthalmol 120 6 2002 835 844 (Pubitemid 34620368)
21. U. Schmidt-Erfurth, S. Michels, I. Barbazetto, H. Laqua Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 3 2002 830 841 (Pubitemid 34184504)
22. S. Michels, U. Schmidt-Erfurth Sequence of early vascular events after photodynamic therapy Invest Ophthalmol Vis Sci 44 5 2003 2147 2154 (Pubitemid 36520311)
23. U. Schltzer-Schrehardt, A. Viestenz, G.O. Naumann, H. Laqua, S. Michels, U. Schmidt-Erfurth Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 9 2002 748 757 (Pubitemid 36104156)
24. U. Schmidt-Erfurth, U. Schltzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, G.O. Naumann Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 10 2003 4473 4480 (Pubitemid 37186285)
25. M. Azab, D.S. Boyer, N.M. Bressler Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial Arch Ophthalmol 123 4 2005 448 457 (Pubitemid 40489914)
26. M.J. Potter, C.C. Claudio, S.M. Szabo A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: the VIA study Br J Ophthalmol 94 2 2010 174 179
27. A. Yamashita, F. Shiraga, C. Shiragami, A. Ono, K. Tenkumo One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 149 3 2010 465 471
28. F. Gomi, M. Sawa, H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
29. T.Y. Lai, W.M. Chan, D.T. Liu, F.O. Luk, D.S. Lam Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 92 5 2008 661 666 (Pubitemid 351684177)
30. T. Sato, S. Kishi, H. Matsumoto, R. Mukai Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 149 6 2010 947 954
31. F. Gomi, M. Sawa, T. Wakabayashi, Y. Sasamoto, M. Suzuki, M. Tsujikawa Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 150 1 2010 48 54
32. P. Ruamviboonsuk, M. Tadarati, S. Vanichvaranont, P. Hanutsaha, N. Pokawattana Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study Br J Ophthalmol 94 8 2010 1045 1051
33. T. Nagasawa, T. Naito, S. Matsushita, H. Sato, T. Katome, H. Shiota Efficacy of intravitreal bevacizumab (Avastin) for short-term treatment of diabetic macular edema J Med Invest 56 3-4 2009 111 115
34. K. Kriechbaum, S. Michels, F. Prager Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 4 2008 518 522 (Pubitemid 351497981)
35. S. Michels, F. Hansmann, W. Geitzenauer, U. Schmidt-Erfurth Influence of treatment parameters on selectivity of verteporfin therapy Invest Ophthalmol Vis Sci 47 1 2006 371 376 (Pubitemid 46780838)
36. M. Matsuoka, N. Ogata, T. Otsuji, T. Nishimura, K. Takahashi, M. Matsumura Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy Br J Ophthalmol 88 6 2004 809 815 (Pubitemid 38725593)
37. J.P. Tong, W.M. Chan, D.T. Liu Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 3 2006 456 462 (Pubitemid 43265948)
38. M. Ghajarnia, S. Kurup, A. Eller The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy Semin Ophthalmol 22 2 2007 127 131 (Pubitemid 46918884)
39. I.K. Kim, D. Husain, N. Michaud Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid Invest Ophthalmol Vis Sci 47 1 2006 357 363 (Pubitemid 46780836)
40. C. Costagliola, M.R. Romano, M. Rinaldi Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration Br J Ophthalmol 94 2 2010 180 184
41. W.K. Lee, P.Y. Lee, S.K. Lee Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence Jpn J Ophthalmol 52 2 2008 108 115 (Pubitemid 351624396)